- Company/Commercial (200)
- Corporate (166)
- Employment (164)
- Litigation / Dispute Resolution (155)
- Banking / Finance (95)
- Regulatory and compliance (63)
- Financial services (46)
- Intellectual Property (43)
- Tax (39)
- Energy (37)
- Competition/EU (35)
- Real Estate (35)
- Information Technology (32)
- Media/Entertainment/Sport (30)
- Pharma/Biotech (30)
- Funds (25)
- Human Rights (24)
- Environment (23)
- Crime (22)
- Insolvency & restructuring (22)
- Healthcare (21)
- Other (21)
- Telecoms (19)
- Insurance/reinsurance (18)
- Private Equity (16)
- Pensions (12)
- Transport (Including aviation and shipping) (12)
- Charities (10)
- Public Sector/Local Authority (10)
- Commodities (9)
- Family (7)
- Travel and Tourism (6)
- Business Tax (5)
- Agriculture (4)
- Construction (4)
- Immigration (4)
- In-House (3)
- Personal Injury (3)
- Personal tax / Trusts (3)
- Planning (3)
- Licensing/Gaming/Betting (2)
- PPP/PFI/Commercial projects (2)
- Private Client (1)
- Professional Indemnity/Negligence (1)
- Suppliers (1)
622 articles matched your search
Sort By: Newest first | Oldest first
Maria Eugenia Ramirez, counsel in Hogan Lovells’ Miami office, has been selected for the 2014 Fellows Program of the Leadership Council on Legal Diversity.
Hogan Lovells has been shortlisted in the Transparency Award category at the Opportunity Now Excellence in Practice Awards 2014.
Hogan Lovells’ ‘Breaking Barriers’ diversity initiative has hosted a series of events across offices in Asia and the Middle East to celebrate International Women’s Day.
Companies in the federal supply chain have an opportunity to prepare for the expansion of government’s anti-human-trafficking rules
This update highlights the salient aspects of the proposed rules and the requirements that are likely to be of most interest to contractors.
Companies should assess their business operations and relationships in Ukraine.
Hogan Lovells’ Ulaanbaatar office has hosted a panel discussion on breaking barriers for professional women, moderated by Solongoo Bayarsaikhan and Nominchimeg Odsuren.
Hogan Lovells is to set up a Legal Services Centre in Birmingham to deliver high-quality cost-effective legal services for aspects of its client work.
Hogan Lovells has been named among the top five law firms with the strongest brand in Acritas’s annual ‘US Law Firms Brand Index 2014’.
Hogan Lovells has advised EuropaCorp on the formation of a US joint venture with Beverly Hills-based Relativity Media.
The energy sector will play a leading role in the global M&A revival, according to wide-ranging research carried out by Hogan Lovells.
The new compensation limits for dismissals taking place on or after 6 April 2014 have been published.
Ever since the Equality Act came in, there has been uncertainty as to whether it covers post-employment victimisation.
Elizabeth Slattery, a partner in Hogan Lovells’ employment team, has commented on a Court of Appeal ruling confirming that post-termination victimisation is unlawful.
The EAT had to decide two main issues: had the claimant made a ‘disclosure’? Did he suffer detriment as a result of that?
Hogan Lovells has been presented with the Restructuring Team of the Year award at the International Finance Law Review (IFLR) Asia Awards during a ceremony in Hong Kong on 26 February.
Hogan Lovells has won asylum for a lesbian woman who feared sexual orientation-based persecution if she was required to return to her native Macedonia.
Anina Boshoff, a finance partner at Edward Nathan Sonnenbergs, is joining Hogan Lovells on 1 March 2014 to head up the banking and finance department in Johannesburg.
Claudette Christian, office managing partner for Hogan Lovells’ Rio de Janeiro and São Paulo offices, has been named International Lawyer of the Year by Latin Lawyer.
Mark Jones and David Moss of Hogan Lovells have commented following the publication of Sir Ian Wood’s ‘UKCS Maximising Recovery’ report.
FDA revises forms for submission of patent information to the Orange Book: Federal Circuit decision alters patent term adjustment
Two recent developments will affect the listing of patent information with pharmaceutical products approved by the US Food and Drug Administration.